The Role of TGF- Signaling Pathways in Cancer and Its Potential As a Therapeutic Target

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2021 Aug 2

PMID 34335834

Citations 28

Authors

Yun Yang

Wen-Long Ye

Ruo-Nan Zhang

Xiao-Shun He

Jing-Ru Wang

Yu-Xuan Liu

Yi Wang

Xue-Mei Yang

Yu-Juan Zhang

Wen-Juan Gan

Affiliations

Soon will be listed here.

Abstract

The transforming growth factor- (TGF-) signaling pathway mediates various biological functions, and its dysregulation is closely related to the occurrence of malignant tumors. However, the role of TGF- signaling in tumorigenesis and development is complex and contradictory. On the one hand, TGF- signaling can exert antitumor effects by inhibiting proliferation or inducing apoptosis of cancer cells. On the other hand, TGF- signaling may mediate oncogene effects by promoting metastasis, angiogenesis, and immune escape. This review summarizes the recent findings on molecular mechanisms of TGF- signaling. Specifically, this review evaluates TGF-'s therapeutic potential as a target by the following perspectives: ligands, receptors, and downstream signaling. We hope this review can trigger new ideas to improve the current clinical strategies to treat tumors related to the TGF- signaling pathway.

Citing Articles

Advanced Therapeutic Approaches for Metastatic Ovarian Cancer.

Choe S, Jeon M, Yoon H Cancers (Basel). 2025; 17(5).

PMID: 40075635 PMC: 11898553. DOI: 10.3390/cancers17050788.

Exploring TGF-β Signaling in Cancer Progression: Prospects and Therapeutic Strategies.

Sheikh K, Amjad M, Irfan M, Anjum S, Majeed T, Riaz M Onco Targets Ther. 2025; 18:233-262.

PMID: 39989503 PMC: 11846535. DOI: 10.2147/OTT.S493643.

The integrative genomic and functional immunological analyses of colorectal cancer initiating cells to modulate stemness properties and the susceptibility to immune responses.

Tout I, Bougarn S, Toufiq M, Gopinath N, Hussein O, Sathappan A J Transl Med. 2025; 23(1):193.

PMID: 39962504 PMC: 11834280. DOI: 10.1186/s12967-025-06176-0.

The Oncogenic Role of , a Long Non-Coding RNA, in Epstein-Barr Virus-Associated Oral Squamous Cell Carcinoma: An Integrative Transcriptome and Functional Analysis.

Srisathaporn S, Pientong C, Heawchaiyaphum C, Nukpook T, Aromseree S, Ekalaksananan T Int J Mol Sci. 2024; 25(23).

PMID: 39684278 PMC: 11641457. DOI: 10.3390/ijms252312565.

Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm.

Dobre A, Nedelcu R, Turcu G, Brinzea A, Struna I, Tudorache G Am J Clin Dermatol. 2024; 26(1):45-59.

PMID: 39572470 PMC: 11742465. DOI: 10.1007/s40257-024-00900-0.

References

Kuratomi G, Komuro A, Goto K, Shinozaki M, Miyazawa K, Miyazono K . NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor. Biochem J. 2004; 386(Pt 3):461-70. PMC: 1134864. DOI: 10.1042/BJ20040738. View

Wu J, Krawitz A, Chai J, Li W, Zhang F, Luo K . Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling. Cell. 2002; 111(3):357-67. DOI: 10.1016/s0092-8674(02)01006-1. View

Chen Y, Lui H, Lin S, Lee J, Ying S . Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood). 2002; 227(2):75-87. DOI: 10.1177/153537020222700201. View

Huynh L, Hipolito C, Ten Dijke P . A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment. Biomolecules. 2019; 9(11). PMC: 6921009. DOI: 10.3390/biom9110743. View

Ohgushi M, Kuroki S, Fukamachi H, OReilly L, Kuida K, Strasser A . Transforming growth factor beta-dependent sequential activation of Smad, Bim, and caspase-9 mediates physiological apoptosis in gastric epithelial cells. Mol Cell Biol. 2005; 25(22):10017-28. PMC: 1280259. DOI: 10.1128/MCB.25.22.10017-10028.2005. View

Jobling M, Mott J, Finnegan M, Jurukovski V, Erickson A, Walian P . Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species. Radiat Res. 2006; 166(6):839-48. DOI: 10.1667/RR0695.1. View

Derynck R, Zhang Y . Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003; 425(6958):577-84. DOI: 10.1038/nature02006. View

Hjelmeland M, Hjelmeland A, Sathornsumetee S, Reese E, Herbstreith M, Laping N . SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility. Mol Cancer Ther. 2004; 3(6):737-45. View

Takekawa M, Tatebayashi K, Itoh F, Adachi M, Imai K, Saito H . Smad-dependent GADD45beta expression mediates delayed activation of p38 MAP kinase by TGF-beta. EMBO J. 2002; 21(23):6473-82. PMC: 136947. DOI: 10.1093/emboj/cdf643. View

10.

Wu H, Sun Y, Wong W, Cui J, Li J, You X . The development of a novel transforming growth factor-β (TGF-β) inhibitor that disrupts ligand-receptor interactions. Eur J Med Chem. 2020; 189:112042. DOI: 10.1016/j.ejmech.2020.112042. View

11.

Liang H, Xu C, Pan Z, Zhang Y, Xu Z, Chen Y . The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis. Mol Ther. 2014; 22(6):1122-1133. PMC: 4048895. DOI: 10.1038/mt.2014.42. View

12.

Perlman R, Schiemann W, Brooks M, Lodish H, Weinberg R . TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol. 2001; 3(8):708-14. DOI: 10.1038/35087019. View

13.

Karimian A, Ahmadi Y, Yousefi B . Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst). 2016; 42:63-71. DOI: 10.1016/j.dnarep.2016.04.008. View

14.

Takasaka N, Seed R, Cormier A, Bondesson A, Lou J, Elattma A . Integrin αvβ8-expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells. JCI Insight. 2018; 3(20). PMC: 6237456. DOI: 10.1172/jci.insight.122591. View

15.

Fransvea E, Angelotti U, Antonaci S, Giannelli G . Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. Hepatology. 2008; 47(5):1557-66. DOI: 10.1002/hep.22201. View

16.

He A, Xie W, Song W, Ma Y, Liu G, Liang M . Platelet releasates promote the proliferation of hepatocellular carcinoma cells by suppressing the expression of KLF6. Sci Rep. 2017; 7(1):3989. PMC: 5479859. DOI: 10.1038/s41598-017-02801-1. View

17.

Bedinger D, Lao L, Khan S, Lee S, Takeuchi T, Mirza A . Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms. MAbs. 2015; 8(2):389-404. PMC: 4966579. DOI: 10.1080/19420862.2015.1115166. View

18.

Lyons R, Keski-Oja J, Moses H . Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol. 1988; 106(5):1659-65. PMC: 2115066. DOI: 10.1083/jcb.106.5.1659. View

19.

Hao Y, Baker D, Ten Dijke P . TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis. Int J Mol Sci. 2019; 20(11). PMC: 6600375. DOI: 10.3390/ijms20112767. View

20.

Gray P, Shani G, Aung K, Kelber J, Vale W . Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling. Mol Cell Biol. 2006; 26(24):9268-78. PMC: 1698529. DOI: 10.1128/MCB.01168-06. View